Careers
WHY PATHOQUEST
We drive innovation in quality testing allowing our customers to develop and deliver new biotherapies rapidly and safely to patients.Â
Innovative biologics must be manufactured to the highest standards of safety and in a timely manner. That’s why PathoQuest has built an extensive team of genomic experts to support our clients with rapid and robust quality controlled (QC) testing at GMP and non-GMP level.Â
Our goal is to transform the future of QC testing for biologic therapies and treatments that improve patient lives. However, we can only achieve this goal by focusing on what matters: teamwork, innovation expertise, speed and quality.
 These new biotherapies are quite literally transforming and often saving lives, and we are privileged to play our part in getting these new treatments to patients.Â
Learn more about working at PathoQuest:
Meet Colette Côté the Chief Portfolio Officer and General Manager of PathoQuest US subsidiary.
OPEN ROLES
If you are interested in what we do and believe you have the passion, experience and expertise to join the PathoQuest team, please send your CV or resume along with a covering letter to office@pathoquest.com
Bioinformatics Engineer
R&D
Bioinformatics Engineer
Operations
News & Events
Webinar – Integration Site Analysis: An innovative method for faster, more certain clone selection & genetic stability testing
Integration Site Analysis: An Innovative Method For Faster, More Certain Clone Selection & Genetic Stability TestingThis webinar will provide information on the new integration site analysis assay PathoQuest has launched. The assay uses Cas9 targeted DNA cleavage...
Substitution of in vitro and in vivo virus testing with PathoQuest NGS confirmed by French Agency.
Substitution of in vitro and in vivo virus testing with PathoQuest NGS confirmed by French AgencyPathoQuest is pleased to announce that the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) have recently published their review of PathoQuest’s...
PathoQuest Announces Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
PathoQuest Announces Publication of a Head-to-Head Study Validating Proprietary NGS Viral Safety Assay as a Reliable Alternative to Animal Testing NGS assay demonstrated a broader detection range than standard in vivo tests with comparable or higher analytical...
Contact us
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
E: contact@pathoquest.com
Sign up for our latest news
France
+33Â (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
How can PathoQuest help?
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
France
+33Â (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
E: contact@pathoquest.com
How can PathoQuest help?
Sign up for our latest news